维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

17篇 您的检索式：作者名="Rizzieri D A"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies显示文摘	Rizzieri D A Feldman E DiPersio J F	2008	Clin Cancer Res2008，14，9：	1
	2	Phase I clinical study of diph-theria toxin - interleukin 3 fusion protein in patients with acutemyeloid leukemia and myelodysplasia 显示文摘	Frankel A Liu JS Rizzieri D	2008	Leuk Lymphoma2008，49，3：	1
	3	Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants显示文摘	Morse M A Rizzieri D Stenzel T T	2002	J Hematotherapy and Stem Cell Research2002，11，：	1
	4	Aphase I study of arsenic trioxide (trisenox) , ascorbic acid, and bortezomib (velcade) combination therapy in patients with relapsed/refractory multiple myeloma 显示文摘	HELD L A RIZZIERI D LONG G D	2013	Cancer Invest2013，31，3：	1
	5	Phase Ⅰ evaluation of prolonged- infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia 显示文摘	Rizzieri D A Bass A J Rosner G L	2002	J Clin Oncol2002，20，：	1
	6	Phase Ⅰ evaluation of prolonged - infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia 显示文摘	Rizzieri D A Ibom V K Moore J O	2003	Clin Cancer Res2003，9，2：	1
	7	A Phase II trial of gemcitabine and mitoxantrone for patients with acute myeloid leukemia in first relapse显示文摘	ADVANI A S SHADMAN M ALI-OSMAN F BARKER A RYBICKI L KALAYCIO M SEKERES M A de CASTRO C M DIEHL L F MOORE J O BEAVEN A COPELAN E SOBECKS R TALEA P RIZZIERI D A	2010	Clinical lymphoma Myeloma & Leukemia2010，10，6：	1
	8	Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune recnnstitution显示文摘	RIZZIERI D A KOH L P LONG G D	2007	J Clin Oncol2007，25，6：	1
	9	Phase I evalution of Pro- tonged-Lnfusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia显示文摘	Rizzieri D A Bass A J Rosner G L	2002	J Clin Oncol2002，20，3：	1
	10	Phase I clinical study of diphtheria toxin-interleukln 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia 显示文摘	Frankel A Liu JS Rizzieri D	2008	Leuk Lymphoma2008，49，3：	1
	11	Phase Ⅰ evalution of Prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia 显示文摘	Rizzieri D A Bass A J Rosner G L	2002	J Clin Oncol2002，20，3：	1
	12	Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen显示文摘	Rizzieri D A Long G D Vredenburgh J J	2001	Blood2001，98，12：	1
	13	Effi cacy and toxicity of rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or Burkitt-like leukemia/lymphoma: Cancer and Leukemia Group B (CALGB) Stud- yl0002显示文摘	RIZZIERI D A JOHNSON J L BYRD J C	2010	Blood2010，116，：	1
	14	Feasibility study of a dose dense induction regimen of high dose cytarabine (HiDAC) and Gemtuzumab Ozogamicin (MylotargTM) for newly diagnosed elderly patients with acute myeloid leukemia显示文摘	RAO A V RIZZIERI D A MOORE O J	2005	Blood2005，106，23：	1
	15	Enhancement of vaccine-mediated antitmnor immunity in cancer patients after depletion of regulatory T cells 显示文摘	Dannull J Su Z Rizzieri D Yang BK Coleman D Yancey D Zhang A	2005	J Clin Invest2005，115，12：	1
	16	Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkin 's lymphoma 显示文摘	Beaven A W Rizzieri D	2012	Clin Invest2012，2，1：	1
	17	Phase I clinical study ofdiphtheria toxin-interleukin 3 fusion protein in patients with acutemyeloid leukemia and myelodysplasia 显示文摘	Frankel A Liu JS Rizzieri D	2008	Leuk Lymphoma2008，49，3：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费